EXPERIENCE OF ADMINISTRATION OF GROWTH HORMONE IN TREATMENT OF DIFFERENT TYPES OF MICROSOMIA IN CHILDREN

V.A. Peterkova; E.V. Nagaeva

EXPERIENCE OF ADMINISTRATION OF GROWTH HORMONE IN TREATMENT OF DIFFERENT TYPES OF MICROSOMIA IN CHILDREN

V.A. Peterkova, E.V. Nagaeva

Abstract

The opportunities of receiving of genetically engineered medications, e.g. somatotropic hormone (STG) are almost unrestricted, and treatment and monitoring of patients with different types of microsomia can be held on modern, new level with the help of it. STG provides normal stature and valuable quality of life in these patients. Treatment with growth hormone influences on hormonal, metabolic and psychical status of patient. Metabolic effects are: increasing of muscle strength, improving of renal blood flow, increasing of cardiac output, absorbability of calcium in intestines and mineralization of bones. The level of blood cholesterol, lipoproteins is descended; blood alkaline phosphatase, phosphorus, urine and fatty acid are increased. Patients' vitality and quality of life are normalized. Besides somatotropic insufficiency, growth hormone is widely used in growth_stimulating treatment of different types of dwarism in children: microsomia due to pre_natal growth delay, genetic syndromes: Silwer–Russell, Shereshevsky–Turner, Nunan, Prader–Willi, and microsomia in patients with chronic renal disease.
Key words: children, microsomia, somatotropic hormone, treatment.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(2):86-93)

About the Authors

V.A. Peterkova

Scientific Center of Endocrinology, Moscow
Russian Federation

E.V. Nagaeva

Scientific Center of Endocrinology, Moscow
Russian Federation

References

1. Дедов И.И., Тюльпаков А.Н., Петеркова В.А. Соматотропная недостаточность. М. 1998. 302 с.

2. Фофанова О.В., Волеводз Н.Н., Безлепкина О.Б. Проект национального консенсуса по диагностике и лечению соматотропной недостаточности у детей. Материалы конференции по детской эндокринологии. М. 2003.

3. Consensus guidelines for the diagnosis and treatment of growth hormone deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J. Clin. Endocrinol. Metab. 2000; 85 (11): 3990–3993.

4. Fidotti E. A history of growth hormone injections devices. J. Pediatr. Endocrinol. Metab. 2001; 14: 497–501.

5. AACE Medical Guidelines for clinical practice: for growth hormone use in adults and children - 2003 Update. Endocr. Pract. 2003; 9: 65–76.

6. Saggese G., Ranke M.B., Saenger P. et al. Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the availability of recombinant human growth hormone. Workshop held in Pisa, Italy, 27–28 March 1998. Horm. Res. 1998; 50: 320–340.

7. Gorman G., Frankenfield D., Fivush B., Neu A. Linear growth in pediatric hemodialysis patients. Pediatr. Nephrol. 2007; 22: 420–429.

8. Kari J.A., Rees L. Growth hormone for children with chronic renal failure and on dialysis. Pediatr. Nephrol. 2005; 20: 618–621.

9. Fine R.N., Kohaut E.C., Brown D. Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. J. Pediatr. 1994; 124: 374–382.

Review

For citations:

Peterkova V., Nagaeva E. EXPERIENCE OF ADMINISTRATION OF GROWTH HORMONE IN TREATMENT OF DIFFERENT TYPES OF MICROSOMIA IN CHILDREN. Current Pediatrics. 2009;8(2):86-93.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Current Pediatrics

EXPERIENCE OF ADMINISTRATION OF GROWTH HORMONE IN TREATMENT OF DIFFERENT TYPES OF MICROSOMIA IN CHILDREN

Abstract

About the Authors

References

Review

For citations:

Cookies policy